Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor

Blood

Volumn 108, Issue 7, 2006, Pages 2229-2236

  Cho, Jaehyung ^a   Mosher, Deane F ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; VON WILLEBRAND FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SHEAR STRESS; THROMBOCYTE; THROMBOGENESIS;

EID: 33749317677     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-02-002063     Document Type: Article

References (37)

1. Mosher D. Fibronectin. San Diego, CA: Academic Press; 1989.
2. Hynes R. Fibronectins. New York, NY: Springer-Verlag; 1990.
3. McKeown-Longo PJ, Mosher DF. Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts. J Cell Biol. 1985;100:364-374.
4. Tomasini-Johansson BR, Kaufman NR, Ensenberger MG, Ozeri V, Hanski E, Mosher DF. A 49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly. J Biol Chem. 2001;276:23430-23439.
5. Olorundare OE, Peyruchaud O, Albrecht RM, Mosher DF. Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists. Blood. 2001;98:117-124.
6. Cho J, Mosher DF. Characterization of assembly of plasma fibronectin by platelets adherent to adsorbed laminin-111. J Thromb Haemost. 2006;4:943-951.
7. Cho J, Degen JL, Coller BS, Mosher DF. Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets: effects of the interaction of alphaIIb beta3 with the C terminus of the fibrinogen gamma-chain. J Biol Chem. 2005;280:35490-35498.
8. Ni H, Yuen PS, Papalia JM, et al. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci U S A. 2003;100:2415-2419.
9. Cho J, Mosher DF. Enhancement of thrombogenesis by plasma fibronectin crosslinked to fibrin and assembled in platelet thrombi. Blood. 2006;107:3555-3563.
10. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227-1234.
11. Kehrel B. Platelet-collagen interactions. Semin Thromb Hemost. 1995;21:123-129.
12. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94:657-666.
13. Bastida E, Escolar G, Ordinas A, Sixma JJ. Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces. Blood. 1987;70:1437-1442.
14. Nievelstein PF, D'Alessio PA, Sixma JJ. Fibronectin in platelet adhesion to human collagen types I and III: use of nonfibrillar and fibrillar collagen in flowing blood studies. Arteriosclerosis. 1988;8:200-206.
15. Houdijk WP, Sakariassen KS, Nievelstein PF, Sixma JJ. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest. 1985;75:531-540.
16. Hynes RO, Ali IU, Destree AT, et al. A large glycoprotein lost from the surfaces of transformed cells. Ann N Y Acad Sci. 1978;312:317-342.
17. Mazurier C, Poulle M, Samor B, Hilbert L, Chtourou S. In vitro study of a triple-secured von Willebrand factor concentrate. Vox Sang. 2004;86:100-104.
18. Venturoni M, Gutsmann T, Fantner GE, Kindt JH, Hansma PK. Investigations into the polymorphism of rat tail tendon fibrils using atomic force microscopy. Biochem Biophys Res Commun. 2003;303:508-513.
19. Mosher DF, Schad PE. Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa. J Clin Invest. 1979;64:781-787.
20. Meyers KM, Holmsen H, Seachord CL. Comparative study of platelet dense granule constituents. Am J Physiol. 1982;243:R454-R461.
21. Tangelder GJ, Slaaf DW, Arts T, Reneman RS. Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles. Am J Physiol. 1988;254:H1059-H1064.
22. Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res. 2004;114:447-453.
23. Farndale RW, Sixma JJ, Barnes MJ, de Groot PG. The role of collagen in thrombosis and hemostasis. J Thromb Haemost. 2004;2:561-573.
24. Ensenberger MG, Tomasini-Johansson BR, Sottile J, Ozeri V, Hanski E, Mosher DF. Specific interactions between F1 adhesin of Streptococcus pyogenes and N-terminal modules of fibronectin. J Biol Chem. 2001;276:35606-35613.
25. Watson SP. Collagen receptor signaling in platelets and megakaryocytes. Thromb Haemost. 1999;82:365-376.
26. Phillips DR, Prasad KS, Manganello J, Bao M, Nannizzi-Alaimo L. Integrin tyrosine phosphorylation in platelet signaling. Curr Opin Cell Biol. 2001;13:546-554.
27. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood. 2003;102:449-461.
28. Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost. 2001;86:189-197.
29. Ishii I, Fukushima N, Ye X, Chun J. Lysophospholipid receptors: signaling and biology. Annu Rev Biochem. 2004;73:321-354.
30. Beacham DA, Wise RJ, Turci SM, Handin RI. Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis. J Biol Chem. 1992;267:3409-3415.
31. Fitzsimmons CM, Cockburn CG, Hornsey V, Prowse CV, Barnes MJ. The interaction of von Willebrand factor (vWf) with collagen: investigation of vWf-binding sites in the collagen molecule. Thromb Haemost. 1988;59:186-192.
32. Kleinman HK, Wilkes CM, Martin GR. Interaction of fibronectin with collagen fibrils. Biochemistry. 1981;20:2325-2330.
33. Pietu G, Fressinaud E, Girma JP, Nieuwenhuis HK, Rothschild C, Meyer D. Binding of human von Willebrand factor to collagen and to collagen-stimulated platelets. J Lab Clin Med. 1987;109:637-646.
34. Lasser G, Guchhait P, Ellsworth JL, et al. C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. Blood. 2006;107:423-430.
35. Furie B, Furie BC. Thrombus formation in vivo. J Clin Invest. 2005;115:3355-3362.
36. Sakai T, Johnson KJ, Murozono M, et al. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med. 2001;7:324-330.
37. Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A. 1998;95:9524-9529.